The "Global Cell Therapy Market Analysis 2019" report has been added to ResearchAndMarkets.com's offering.
The Cell Therapy market is expected to reach $9.76 billion by 2026 growing at a CAGR of 7.2% from 2018 to 2026.
Cell therapy is a technology which relies on replacing diseased or dysfunctional cells with healthy functioning ones. Cells mainly used for such advanced therapies are stem cells, because of their ability to differentiate into the specific cells required for repairing damaged or defective tissues or cells. Moreover, cell therapy finds its application in the development of regenerative medicines which is a multidisciplinary area aimed at maintenance, improvement, or restoration of a cell, tissue, or organ function using methods mainly related to cell therapy.
Factors such as rising funding from the government as well as private organizations to support cell therapy clinical trials, growing adoption of regenerative medicine and increase in the incidence of diseases such as cancer, cardiac abnormalities are fuelling the market growth. However, the implementation of stringent government regulations regarding the use of cell therapy is anticipated to restrict the growth of the market.
By Therapy Type, Autologous therapies are going to have a significant rate during the forecast period owing to several advantages offered by them such as availability, lower risk of life-threatening complications, low rate of graft failure, low mortality rate, higher affordability and high survival rate of patients. Autologous cell therapy is a branch of regenerative medicine. It involves biologic cell-based therapies to cure various diseases related to oncology, dermatology, and neurology, among others.
The key vendors mentioned are MEDIPOST, AlloCure, Cell Medica, Kolon TissueGene, Inc., Arteriocyte Medical Systems, Forticell Bioscience, Athersys Inc., Stemedica Cell Technologies, Inc., Vericel Corporation, Baxter Healthcare Corporation, JCR Pharmaceuticals Co., Ltd., Osiris Therapeutics, Inc., Bone Therapeutics, Cellerant Therapeutics, Celgene Corporation, PHARMICELL Co., Ltd, FibrocellScinence, NuVasive, Inc, and ANTEROGEN.CO., LTD.
Key Questions Answered in this Report:
- How this market evolved since the year 2016
- Market size estimations, forecasts and CAGR for all the segments presented in the scope
- Key Market Developments and financials of the key players
- Opportunity Analysis for the new entrants
- SWOT Analysis of the key players
- Fastest growing markets analysed during the forecast period
Key Topics Covered:
1 Market Synopsis
2 Research Outline
3 Market Dynamics
4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Cell Therapy Market, By Therapy Type
5.2 Autologous Therapies
5.3 Allogenic Therapies
6 Global Cell Therapy Market, By Cell Type
6.2 Non-Stem Cell
6.3 Stem Cell
7 Global Cell Therapy Market, By Use & Type
8 Global Cell Therapy Market, By Therapeutic
8.2 Musculoskeletal Disorders
8.5 Autoimmune Disorders
8.6 Other Therapeutics
9 Global Cell Therapy Market, By Technology
9.2 Cell Immortalization Technology
9.3 Genome Editing Technology
9.4 Viral Vector Technology
10 Global Cell Therapy Market, By Product
10.5 Other Services
11 Global Cell Therapy Market, By Cell Source
11.2 Adipose Tissue
11.3 Umbilical Cord Blood-Derived Cells
11.4 Bone Marrow
12 Global Cell Therapy Market, By Technique
12.2 Fibroblast Cell Therapy
12.3 Cell Vaccine
12.4 Stem Cell Therapy
12.5 Chondrocyte Cell Therapy
12.6 Adoptive Cell Transfer (ACT)
13 Global Cell Therapy Market, By Application
13.2 Cardiovascular Disease (CVD)
13.4 Wound Healing
14 Global Cell Therapy Market, By End User
14.2 Regenerative Medicine Centers
14.3 Academic & Research Institutes
14.4 Hospital & Clinics
15 Global Cell Therapy Market, By Geography
15.1 North America
15.3 Asia Pacific
15.4 South America
15.5 Middle East & Africa
16 Strategic Benchmarking
17 Vendors Landscape
17.3 Cell Medica
17.4 Kolon TissueGene, Inc.
17.5 Arteriocyte Medical Systems
17.6 Forticell Bioscience
17.7 Athersys Inc.
17.8 Stemedica Cell Technologies, Inc.
17.9 Vericel Corporation
17.10 Baxter Healthcare Corporation
17.11 JCR Pharmaceuticals Co., Ltd.
17.12 Osiris Therapeutics, Inc.
17.13 Bone Therapeutics
17.14 Cellerant Therapeutics
17.15 Celgene Corporation
17.16 PHARMICELL Co., Ltd
17.18 NuVasive, Inc
17.19 ANTEROGEN.CO., LTD
For more information about this report visit https://www.researchandmarkets.com/r/slnpfl
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900